Top Markets
#1 Zora Zora +32.72%
#2 SAFEcoin SAFEcoin +24.00%
#3 0G 0G +21.53%
#4 Full Moon Full Moon +18.68%
#5 Merlin's Seal BTC Merlin's Seal BTC +16.67%
#6 Axelar Axelar +16.33%
#7 VVS Finance VVS Finance +15.88%
#8 SkyAI SkyAI +14.30%
#9 Cysic Cysic +14.24%
#10 Apertum Apertum +14.01%
Coin of the day
Zora Zora
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Albireo Pharma, Inc. Albireo Pharma, Inc.

Albireo Pharma, Inc.

ALBO
Classement en actions #12828
Albireo Pharma, Inc. is a biopharmaceutical company with marketed products,... Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis. Bylvay is also in advanced (Phase III) clinical trials for further pediatric indications such as biliary atresia and Alagille syndrome, which are both uncommon and serious childhood disorders. Additionally, Albireo offers Elobixibat, prescribed for the management of persistent constipation and other functional gastrointestinal issues. Albireo is further advancing its pipeline with A3907, currently undergoing early-stage (Phase I) clinical investigation for adult liver diseases, and A2342, a preclinical candidate designed to address adult viral and liver conditions. The company holds a licensing agreement with EA Pharma Co., Ltd. concerning the development and market rollout of Elobixibat. Albireo Pharma, Inc.'s headquarters are located in Boston, Massachusetts.
Prix de l'action
$44.15
Dernière synchronisation: 2023-03-02
Capitalisation boursière
$545.52M
Changement (1 jour)
-0.23%
Changement (1 an)
0.00%
Pays
US
Échange Albireo Pharma, Inc. (ALBO)

Catégorie

Healthcare
Historique des dividendes pour Albireo Pharma, Inc. (ALBO)
Albireo Pharma, Inc. (symbole boursier : ALBO) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Albireo Pharma, Inc. (ALBO) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH